NCT04415723

Brief Summary

Efficient health care systems for the management of chronic diseases in the community may improve clinical outcomes and simultaneously encourage patients to remain healthy. Supportive care, may contribute to empower heart failure (HF) patients for self- management and providing them with the follow-up and care based on their needs and values through the HF trajectory. To develop the current program an assessment of the support needs of HF patients' will be undertaken and the investigators will take into consideration of their personal preferences, for instance means of communication and way of exercise as part of the intervention. The present study aspires to evaluate the effectiveness of an individualized supportive care management program in terms of the four different components that comprise supportive care in HF. The objectives of this study are to:

  1. 1.Determine supportive care needs of HF patients as reported in the literature.
  2. 2.Explore Cypriot patients' identified supportive care needs.
  3. 3.To develop and test a self-management supportive care programme for HF patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P50-P75 for not_applicable heart-failure

Timeline
Completed

Started Jan 2019

Typical duration for not_applicable heart-failure

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 15, 2019

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

March 4, 2020

Completed
3 months until next milestone

First Posted

Study publicly available on registry

June 4, 2020

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2021

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2022

Completed
Last Updated

June 4, 2020

Status Verified

May 1, 2020

Enrollment Period

2 years

First QC Date

March 4, 2020

Last Update Submit

May 31, 2020

Conditions

Keywords

heart failuresupportive caremanagement programmeperson-centered care

Outcome Measures

Primary Outcomes (25)

  • Minnessota Living with Heart Failure Questionnaire (Greek Version) MLHFQ (Gr version)

    Quantitative data. MLHFQ consists of 21 items using a six-point Likert scale (scored 0-5), resulting in a total score in the range of 0-105, with higher scores reflecting poorer quality of life.

    Baseline

  • Minnessota Living with Heart Failure Questionnaire (Greek Version) MLHFQ (Gr version)

    quantitative data The items of the questionnaire examines 3 dimentions. The dimension scores were calculated as the sum of the items that represent each dimension. Higher scores indicate worse quality of life.

    1st month

  • Minnessota Living with Heart Failure Questionnaire (Greek Version) MLHFQ (Gr version)

    Quantitative data. MLHFQ consists of 21 items using a six-point Likert scale (scored 0-5), resulting in a total score in the range of 0-105, with higher scores reflecting poorer quality of life.

    3rd month

  • Minnessota Living with Heart Failure Questionnaire (Greek Version) MLHFQ (Gr version)

    Quantitative data. MLHFQ consists of 21 items using a six-point Likert scale (scored 0-5), resulting in a total score in the range of 0-105, with higher scores reflecting poorer quality of life.

    6th month

  • Minnessota Living with Heart Failure Questionnaire (Greek Version) MLHFQ (Gr version)

    Quantitative data. MLHFQ consists of 21 items using a six-point Likert scale (scored 0-5), resulting in a total score in the range of 0-105, with higher scores reflecting poorer quality of life.

    one year

  • Audit of Diabetes Dependent Quality of Life - 19 Items ADDQoL-19 (Gr version)

    quantitative data Individual domains of the questionnaire and Average Weighted Impact Score of the indivudual domains scores show maximum negative impact of diabetes (-9) and maximum positive impact of diabetes (+3)

    Baseline

  • Audit of Diabetes Dependent Quality of Life - 19 Items ADDQoL-19 (Gr version)

    quantitative data Individual domains of the questionnaire and Average Weighted Impact Score of the indivudual domains scores show maximum negative impact of diabetes (-9) and maximum positive impact of diabetes (+3)

    1st month

  • Audit of Diabetes Dependent Quality of Life - 19 Items ADDQoL-19 (Gr version)

    quantitative data Individual domains of the questionnaire and Average Weighted Impact Score of the indivudual domains scores show maximum negative impact of diabetes (-9) and maximum positive impact of diabetes (+3)

    3rd month

  • Audit of Diabetes Dependent Quality of Life - 19 Items ADDQoL-19 (Gr version)

    quantitative data Individual domains of the questionnaire and Average Weighted Impact Score of the indivudual domains scores show maximum negative impact of diabetes (-9) and maximum positive impact of diabetes (+3)

    6th month

  • Audit of Diabetes Dependent Quality of Life - 19 Items ADDQoL-19 (Gr version)

    quantitative data Individual domains of the questionnaire and Average Weighted Impact Score of the indivudual domains scores show maximum negative impact of diabetes (-9) and maximum positive impact of diabetes (+3)

    one year

  • Multidimensional Scale of Perceived Social Support (Greek Version) MSPSS (Gr version)

    Quantitative data MSPSS consists of 12 items using a six-point Likert scale (scored 1-7), resulting in a total score in the range of 12-84.The dimension scores were calculated as the summation of the items that repreresent each dimenson \[ 1. Family/Significant others , 2. Friends\] . Higher scores indicate higher perceived social support by Friends and Family/Signifciant Others.

    Baseline

  • Multidimensional Scale of Perceived Social Support (Greek Version) MSPSS (Gr version)

    Quantitative data MSPSS consists of 12 items using a six-point Likert scale (scored 1-7), resulting in a total score in the range of 12-84.The dimension scores were calculated as the summation of the items that repreresent each dimenson \[ 1. Family/Significant others , 2. Friends\] . Higher scores indicate higher perceived social support by Friends and Family/Signifciant Others.

    1st month

  • Multidimensional Scale of Perceived Social Support (Greek Version) MSPSS (Gr version)

    Quantitative data MSPSS consists of 12 items using a six-point Likert scale (scored 1-7), resulting in a total score in the range of 12-84.The dimension scores were calculated as the summation of the items that repreresent each dimenson \[ 1. Family/Significant others , 2. Friends\] . Higher scores indicate higher perceived social support by Friends and Family/Signifciant Others.

    3rd month

  • Multidimensional Scale of Perceived Social Support (Greek Version) MSPSS (Gr version)

    Quantitative data MSPSS consists of 12 items using a six-point Likert scale (scored 1-7), resulting in a total score in the range of 12-84.The dimension scores were calculated as the summation of the items that repreresent each dimenson \[ 1. Family/Significant others , 2. Friends\] . Higher scores indicate higher perceived social support by Friends and Family/Signifciant Others.

    6th month

  • Multidimensional Scale of Perceived Social Support (Greek Version) MSPSS (Gr version)

    Quantitative data MSPSS consists of 12 items using a six-point Likert scale (scored 1-7), resulting in a total score in the range of 12-84.The dimension scores were calculated as the summation of the items that repreresent each dimenson \[ 1. Family/Significant others , 2. Friends\] . Higher scores indicate higher perceived social support by Friends and Family/Signifciant Others.

    one year

  • Hospital and Anxiety- Depression Scale (Greek Version) HADS (Gr version)

    Quantitative data The HADS is a self-report rating scale of 14 items on a 4-point Likert scale (range 0-3). It is designed to measure anxiety and depression (7 items for each subscale). The total score is the sum of the 14 items, and for each subscale the score is the sum of the respective seven items (ranging from 0-21). Higher scores indicate worse quality of life.

    Baseline

  • Hospital and Anxiety- Depression Scale (Greek Version) HADS (Gr version)

    Quantitative data The HADS is a self-report rating scale of 14 items on a 4-point Likert scale (range 0-3). It is designed to measure anxiety and depression (7 items for each subscale). The total score is the sum of the 14 items, and for each subscale the score is the sum of the respective seven items (ranging from 0-21). Higher scores indicate worse quality of life.

    1st month

  • Hospital and Anxiety- Depression Scale (Greek Version) HADS (Gr version)

    Quantitative data The HADS is a self-report rating scale of 14 items on a 4-point Likert scale (range 0-3). It is designed to measure anxiety and depression (7 items for each subscale). The total score is the sum of the 14 items, and for each subscale the score is the sum of the respective seven items (ranging from 0-21). Higher scores indicate worse quality of life.

    3rd month

  • Hospital and Anxiety- Depression Scale (Greek Version) HADS (Gr version)

    Quantitative data The HADS is a self-report rating scale of 14 items on a 4-point Likert scale (range 0-3). It is designed to measure anxiety and depression (7 items for each subscale). The total score is the sum of the 14 items, and for each subscale the score is the sum of the respective seven items (ranging from 0-21). Higher scores indicate worse quality of life.

    6th month

  • Hospital and Anxiety- Depression Scale (Greek Version) HADS (Gr version)

    Quantitative data The HADS is a self-report rating scale of 14 items on a 4-point Likert scale (range 0-3). It is designed to measure anxiety and depression (7 items for each subscale). The total score is the sum of the 14 items, and for each subscale the score is the sum of the respective seven items (ranging from 0-21). Higher scores indicate worse quality of life.

    one year

  • International Physical Activity Questionnaire (Greek Version) IPAQ (Gr version)

    quantitative data In the classification of perceived physical activity via the IPAQ there were three categories ˙ low activity level, moderate activity and high activity level

    Baseline

  • International Physical Activity Questionnaire (Greek Version) IPAQ (Gr version)

    quantitative data In the classification of perceived physical activity via the IPAQ there were three categories ˙ low activity level, moderate activity and high activity level

    1st month

  • International Physical Activity Questionnaire (Greek Version) IPAQ (Gr version)

    quantitative data In the classification of perceived physical activity via the IPAQ there were three categories ˙ low activity level, moderate activity and high activity level

    3rd month

  • International Physical Activity Questionnaire (Greek Version) IPAQ (Gr version)

    quantitative data In the classification of perceived physical activity via the IPAQ there were three categories ˙ low activity level, moderate activity and high activity level

    6th month

  • International Physical Activity Questionnaire (Greek Version) IPAQ (Gr version)

    quantitative data In the classification of perceived physical activity via the IPAQ there were three categories ˙ low activity level, moderate activity and high activity level

    one year

Secondary Outcomes (15)

  • Self -Care of Heart Failure Index (Greek Version) SCHFI -Gr

    Baseline

  • Self -Care of Heart Failure Index (Greek Version) Gr-SCHFI

    1st month

  • Self -Care of Heart Failure Index (Greek Version) Gr-SCHFI

    3rd month

  • Self -Care of Heart Failure Index (Greek Version) Gr-SCHFI

    6th month

  • Self -Care of Heart Failure Index (Greek Version) Gr-SCHFI

    one year

  • +10 more secondary outcomes

Study Arms (2)

intervention group

EXPERIMENTAL

supportive care management programme

Other: supportive care management programme

control group

NO INTERVENTION

receive the usual care provided by the health care system of Cyprus

Interventions

nurse-led management programme

intervention group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • clinical diagnoses with HF (HFpEF or HFrEF), established by a cardiologist
  • New York Heart Association classification stages I-IV
  • Diagnosis established for at least 6 months before the start of the intervention period
  • Ability to understand, write and read in Greek language

You may not qualify if:

  • Refuse to take part in the research
  • Dementia or other severe mental illness
  • Transfer to nursing homes after discharge
  • Difficulty in contacting them by a phone call
  • Patients with chronic degenerative diseases (Alzheimer, cancer, etc)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cyprus University of Technology; Nursing Department

Limassol, 3036, Cyprus

RECRUITING

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Officials

  • Ekaterini Lambrinou, PhD,MSc,BSc

    Cyprus University of Technology

    STUDY DIRECTOR

Central Study Contacts

Ekaterini Lambrinou, BSc,MSc,PhD

CONTACT

Martha Kyriakou, BSc,MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
single-blinded
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: one intervention group one control group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 4, 2020

First Posted

June 4, 2020

Study Start

January 15, 2019

Primary Completion

January 15, 2021

Study Completion

January 15, 2022

Last Updated

June 4, 2020

Record last verified: 2020-05

Data Sharing

IPD Sharing
Will not share

only the 2 investigators of the study will share data

Locations